The Latest Trading Price of Sandu Pharmaceuticals Ltd is ₹ 44 as of 30 Apr 15:30
. The P/E Ratio of Sandu Pharmaceuticals Ltd is 33.3 as of March 2023
.The P/E Ratio of Source Natural Foods & Herbal Supplements Ltd is 0 as of March 2023
. The Market Cap of Sandu Pharmaceuticals Ltd is ₹ 50.43 crore as of March 2023
.The Market Cap of Source Natural Foods & Herbal Supplements Ltd is ₹ 0 crore as of March 2023
. The revenue of Sandu Pharmaceuticals Ltd for the Mar '25 is ₹ 14.14 crore as compare to the Dec '24 revenue of ₹ 18.4 crore. This represent the decline of -23.15% The revenue of Source Natural Foods & Herbal Supplements Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Sandu Pharmaceuticals Ltd for the Mar '25 is ₹ 0.52 crore as compare to the Dec '24 ebitda of ₹ 1.02 crore. This represent the decline of -49.02% The ebitda of Source Natural Foods & Herbal Supplements Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Sandu Pharmaceuticals Ltd changed from ₹ 0.17 crore to ₹ 0.33 crore over 4 quarters. This represents a CAGR of 94.12%
The net profit of Source Natural Foods & Herbal Supplements Ltd changed from ₹ 0 crore to ₹ 0 crore over 4 quarters. This represents a CAGR of 0.0%
The Dividend Payout of Sandu Pharmaceuticals Ltd changed from 36.33 % on March 2021 to 49.86 % on March 2025 . This represents a CAGR of 6.54% over 5 yearsThe Dividend Payout of Source Natural Foods & Herbal Supplements Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .
About Sandu Pharmaceuticals Ltd
Sandu Pharmaceuticals Ltd (SPL) was established in 1985.
The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name SANDU.
SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.'94, to part-finance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations.
This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards.
Ayurvedic products have a very good market in India and abroad due to their minimal side effects.
The company commenced commercial production of Ayurvedic Medicines & Formulations, at the Goa plant in 1996-97.
Thereafter, it commenced production of manufacturing Unit II in Goa from May, 2002.
About Source Natural Foods & Herbal Supplements Ltd
Source Natural Foods &Herbal Supplements Limited was formerly incorporated as Inwinex Pharmaceuticals Limited in 1995.
The Company name was then changed from Inwinex Pharmaceuticals Limited to Source Natural Foods &Herbal Supplements Limited in 2011-12.
The Company engages in the pharmaceutical business in India.
It provides allopathic and ayurvedic formulations.
Its principal products include Organic Ashwagandha, Organic Triphala, and Organic Satavari Tablets.
Company operates in the Ayurveda and herbal sphere which has been identified as one of the key sectors of growth and innovation for the Country.
FAQs for the comparison of Sandu Pharmaceuticals Ltd and Source Natural Foods & Herbal Supplements Ltd
Which company has a larger market capitalization, Sandu Pharmaceuticals Ltd or Source Natural Foods & Herbal Supplements Ltd?
Market cap of Sandu Pharmaceuticals Ltd is 42 Cr while Market cap of Source Natural Foods & Herbal Supplements Ltd is 81 Cr
What are the key factors driving the stock performance of Sandu Pharmaceuticals Ltd and Source Natural Foods & Herbal Supplements Ltd?
The stock performance of Sandu Pharmaceuticals Ltd and Source Natural Foods & Herbal Supplements Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Sandu Pharmaceuticals Ltd and Source Natural Foods & Herbal Supplements Ltd?
As of May 4, 2026, the Sandu Pharmaceuticals Ltd stock price is INR ₹44.0. On the other hand, Source Natural Foods & Herbal Supplements Ltd stock price is INR ₹127.3.
How do dividend payouts of Sandu Pharmaceuticals Ltd and Source Natural Foods & Herbal Supplements Ltd compare?
To compare the dividend payouts of Sandu Pharmaceuticals Ltd and Source Natural Foods & Herbal Supplements Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.